Alkermes (ALKS) Shares Outstanding (2010 - 2026)
Alkermes (ALKS) reported Shares Outstanding of $183.6 million for Q1 2026, up 1.89% year-over-year from $180.2 million in Q1 2025, and up 1.43% quarter-over-quarter from $181.0 million in Q4 2025.
Alkermes (ALKS) Shares Outstanding (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Shares Outstanding data on file, last reported at $183.6 million in Q1 2026.
- Shares Outstanding for Q1 2026 came in at $183.6 million, up 1.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.6 million (up 1.89% YoY), and the FY2025 annual result was $181.0 million, up 2.46% from the prior year.
- Shares Outstanding improved to $183.6 million in Q1 2026 per ALKS's latest filing, from $181.0 million in the prior quarter.
- Over five years, Shares Outstanding peaked at $183.6 million in Q1 2026 and troughed at -$4.5 million in Q1 2022.
- A 5-year average of $164.7 million and a median of $175.7 million in 2024 frame the typical range for Shares Outstanding.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding sank 102.76% in 2022, then soared 3885.09% in 2023.
- A 5-year view of Shares Outstanding shows it stood at $169.0 million in 2022, then rose by 2.14% to $172.6 million in 2023, then climbed by 2.38% to $176.7 million in 2024, then advanced by 2.46% to $181.0 million in 2025, then gained by 1.43% to $183.6 million in 2026.
- Business Quant data shows ALKS's Shares Outstanding at $183.6 million in Q1 2026, $181.0 million in Q4 2025, and $180.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.27 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 420.35 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 77.13 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 499.38 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 183.59 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 230.70 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 65.07 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 88.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Mar 31, 2026 | 183.59 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Sep 30, 2025 | 180.50 Mn |
| Sep 30, 2025 | 180.50 Mn |
| Sep 30, 2025 | 180.50 Mn |
| Sep 30, 2025 | 180.50 Mn |